In addition, DLAT mutation frequencies were found to be the highest in uterine corpus endometrial carcinoma (UCEC), BLCA, colon adenocarcinoma/rectum adenocarcinoma esophageal carcinoma (COADREAD), skin cutaneous melanoma (SKCM), and stomach adenocarcinoma (STAD) (Suppl. This evidence concerns the gene DLAT and bladder transitional cell carcinoma.